Ovid Therapeutics Inc.

OVID | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.83

+$0.12 (+4.43%)

Sep 22, 2026, 2:22 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	733K	n/a	718K	132K	6.27M	130K	76K	173K	169K	148K	142K	109K	75K	66K	46.28K	11.1K	n/a	1.45M	n/a	n/a	n/a	208.38M
Cost of Revenue	n/a	35K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	56.87K	n/a	n/a	n/a
Gross Profit	733K	-35K	718K	132K	6.27M	130K	76K	173K	169K	148K	142K	109K	75K	66K	46.28K	11.1K	n/a	1.45M	-56.87K	n/a	n/a	208.38M
Operating Income	-15.7M	-17.85M	-12.29M	-12.52M	-5.07M	-12.55M	-10.72M	-13.23M	-20.52M	-17.42M	-18.19M	-12.03M	-14.17M	-14.89M	-12.17M	-12.8M	-14.3M	-16.27M	-26.35M	-11.68M	-14.31M	176.56M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-15.01M	-16.99M	9.66M	-12.16M	-4.68M	-10.24M	-9.25M	-14.01M	8.52M	-11.69M	-15.32M	-11.25M	-12.41M	-13.36M	-11.5M	-11.97M	-14.59M	-16.06M	-26.35M	-11.68M	-14.32M	176.51M
Net Income	-15.01M	-16.99M	9.66M	-12.16M	-4.68M	-10.24M	-9.25M	-14.01M	8.52M	-11.69M	-15.32M	-11.25M	-12.41M	-13.36M	-11.5M	-11.97M	-14.59M	-16.11M	-25.15M	-11.38M	-15.79M	176.01M
Selling & General & Admin	6.47M	6.67M	6.42M	6.79M	4.88M	6.02M	6.78M	5.54M	8.1M	7.17M	6.19M	6.81M	7.25M	8.34M	7.36M	7.63M	8.26M	9.88M	8.23M	6.76M	6.63M	15.58M
Research & Development	9.96M	11.15M	6.59M	5.87M	6.47M	6.66M	5.92M	7.86M	12.58M	10.4M	10.64M	5.33M	6M	6.62M	5.56M	5.18M	6.05M	7.83M	18.07M	4.92M	7.68M	16.25M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	-1.9M	n/a	1	n/a	1.5M	n/a	1M	-999	-700K	-295	617	203	n/a	341	-842	554
Operating Expenses	16.43M	17.81M	13.01M	12.66M	11.35M	12.68M	10.8M	13.4M	20.69M	17.57M	18.33M	12.14M	14.25M	14.96M	12.22M	12.81M	14.3M	17.71M	26.3M	11.68M	14.31M	31.83M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	16.43M	17.85M	13.01M	12.66M	11.35M	12.68M	10.8M	13.4M	20.69M	17.57M	18.33M	12.14M	14.25M	14.96M	12.22M	12.81M	14.3M	17.71M	26.35M	11.68M	14.31M	31.83M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	50K	-349.71K	-294.83K	1.47M	500.28K
Shares Outstanding (Basic)	197.45M	73.74M	81.67M	71.11M	71.11M	71.05M	71.01M	70.98M	70.92M	70.72M	70.69M	70.62M	70.53M	70.3M	70.47M	70.4M	69.47M	70.04M	67.51M	66.97M	67.82M	66.09M
Shares Outstanding (Diluted)	197.45M	73.74M	81.67M	71.11M	71.11M	71.05M	71.01M	70.98M	71.2M	70.72M	70.69M	70.62M	70.53M	70.49M	70.47M	70.43M	70.39M	70.35M	68.16M	67.93M	67.82M	66.58M
EPS (Basic)	-0.08	-0.23	0.12	-0.17	-0.07	-0.14	-0.13	-0.20	0.12	-0.17	-0.22	-0.16	-0.18	-0.19	-0.16	-0.16	-0.21	-0.23	-0.38	-0.17	-0.23	2.55
EPS (Diluted)	-0.08	-0.23	0.12	-0.17	-0.07	-0.14	-0.13	-0.20	0.12	-0.17	-0.22	-0.16	-0.18	-0.19	-0.16	-0.16	-0.21	-0.23	-0.38	-0.17	-0.23	2.53
EBITDA	-16.39M	-16.95M	9.68M	-12.14M	-4.59M	-10.09M	-10.76M	-13.84M	8.67M	-11.56M	-16.35M	-11.11M	-13.04M	-14.75M	-12.69M	-12.39M	-13.85M	-16.19M	-26.29M	-11.63M	-14.26M	176.63M
EBIT	-16.39M	-16.99M	9.66M	-12.16M	-4.68M	-10.24M	-10.92M	-14.01M	8.52M	-11.69M	-16.49M	-11.25M	-13.17M	-14.89M	-12.87M	-12.8M	-14.3M	-16.27M	-26.35M	-11.68M	-14.31M	176.56M
Depreciation & Amortization	n/a	35K	17K	16K	99K	141K	160K	169K	148K	136K	140K	146K	137K	145K	184.98K	415.37K	452.48K	73.81K	56.87K	52.18K	53.22K	74.74K